DCM
IMNM icon

Driehaus Capital Management’s Immunome IMNM Stock Holding History

Driehaus Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.1M Buy
4,346,139
+246,238
+6% +$5.27M 0.53% 56
2026
Q1 		$89.7M Buy
4,099,901
+393,927
+11% +$8.77M 0.66% 34
2025
Q4 		$79.6M Buy
3,705,974
+3,009,423
+432% +$52.8M 0.54% 53
2025
Q3 		$8.16M Buy
696,551
+475,551
+215% +$4.73M 0.06% 293
2025
Q2 		$2.06M Sell
221,000
-389,551
-64% -$3.19M 0.02% 331
2025
Q1 		$4.11M Buy
+610,551
New +$5.86M 0.04% 306

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Driehaus Capital Management's IMNM Position: Q2 2026 in Review

Driehaus Capital Management increased its Immunome (IMNM) stake by 6% in Q2 2026, buying an estimated $5.27M and bringing the position to 4,346,139 shares worth $92.1M. The position accounts for 0.53% of the portfolio, ranked #56.

Driehaus Capital Management first reported a position in IMNM in Q1 2025 and has held it in 6 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Driehaus Capital Management held 4,346,139 shares of Immunome worth $92.1M as of Q2 2026.
  • Driehaus Capital Management bought 246,238 Immunome shares in Q2 2026, an estimated $5.27M.
  • Immunome made up 0.53% of Driehaus Capital Management's portfolio in Q2 2026, its #56 holding.
  • Driehaus Capital Management first reported a position in Immunome in Q1 2025 and has held it in 6 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.